Quarantine and Release in Pharmaceutical Warehousing

What quarantine and release means

Not all stock in a warehouse is ready to sell. Newly received product may await checks; returns may need assessment; some product may be held pending a quality decision. Quarantine keeps this stock physically separate; release is the approval that moves it into sellable, pickable inventory.

Why the separation has to be physical

Without quarantine, unverified or non-conforming product could be distributed by mistake — a serious compliance and safety risk. Segregating stock until it is released protects both the customer's compliance position and the integrity of the medicines being distributed.

How SFIMS handles it

SFIMS maintains segregated quarantine areas so that quarantined, returned and released stock never mix. Product moves into sellable storage only once approved, and returns follow a defined path rather than going straight back into pickable inventory.

What makes an area genuinely quarantine

A quarantine area is defined by what cannot happen in it rather than by its label:

• Physically separate, so stock cannot be picked from it by accident.
• Clearly identified, so its status is obvious to anyone walking past.
• Access controlled, so only authorised staff move stock in or out.
• System-blocked, so the stock is unavailable to allocation as well as physically apart.
• Correctly conditioned, because chilled stock awaiting release still needs to be chilled.

That last one is missed surprisingly often. A quarantine area with no temperature control can only hold ambient stock, which means either chilled goods are released too quickly or they are quarantined in the wrong conditions.

The release decision itself

Release is a judgement with a name attached, not a status change.

The person releasing confirms that the goods match their documentation, that the quantity and condition are as expected, that any temperature record for the journey is within range or has been assessed, that batch and expiry are recorded correctly, and that any outstanding query has been resolved.

The record should show who released it, when, and on what basis. The test of a release process is whether, eighteen months later, you can say who made the decision and what they saw. A system that logs only a status change cannot answer that.

Stock that is not released

Quarantine has two exits, and the second needs as much process as the first.

Rejected stock should move to a separate, clearly identified rejects area rather than remaining in quarantine, because quarantine is for undecided stock and mixing the two erodes both. The reason for rejection is recorded. The supplier or product holder is notified where the contract requires it. Disposal follows a documented route with evidence retained, and controlled substances follow their own witnessed destruction process.

The failure to avoid is rejected stock lingering in quarantine for months because no one owns the decision. It occupies conditioned space, confuses counts, and eventually somebody puts it back.